RMTI
Rockwell Medical Inc
8.70$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Rockwell Medical Inc (RMTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -0.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.2 | -2.3 | -0.9 | -0.5 | -0.9 | -1.1 | 0.2 | 1.0 | -0.5 | -3.4 | -3.4 | -4.3 | -1.4 | 2.1 | -11 | -31 | -51 | 4.3 | -16 | -12 | -21 | -20 | -27 | -30 | -34 | -17 | -9.4 | 4.2 | -0.7 | |
| 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 0.9 | 1.2 | 1.4 | 1.2 | 1.1 | 1.0 | 1.0 | 0.8 | 0.8 | 0.5 | 0.7 | 2.7 | 2.3 | 2.5 | 0.6 | 1.4 | 2.2 | 2.2 | |
| – | – | – | – | – | – | – | – | – | – | – | 1.5 | 0.4 | 4.0 | 4.4 | 7.3 | 7.7 | 10 | 8.9 | 10 | 7.2 | 4.4 | 5.0 | 0.5 | 0.9 | 0.3 | 0.9 | 1.3 | 1.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.5 | 5.1 | 6.1 | 11 | 9.0 | 10 | 7.7 | 14 | 6.2 | 1.6 | 1.1 | 0.9 | – | – | – | |
| 0.5 | -0.9 | -0.3 | 0.1 | 0.0 | -0.6 | -0.3 | 0.2 | -1.3 | 0.4 | -0.8 | 1.2 | 0.5 | -0.6 | 5.0 | 15 | -11 | 13 | -8.7 | -3.8 | -3.7 | -3.4 | -2.0 | -3.0 | -4.8 | -2.1 | -7.2 | -1.5 | -1.6 | |
| 0.6 | 0.4 | 0.0 | 0.3 | 1.0 | 0.4 | 0.2 | 0.4 | 0.6 | 1.0 | 0.9 | 1.3 | 1.6 | 0.8 | 0.6 | 0.5 | 0.7 | 0.7 | 0.8 | 0.4 | 1.7 | 1.0 | 1.3 | 1.0 | 0.5 | 0.3 | 0.3 | 1.0 | 0.5 | |
| -0.6 | -0.4 | – | -0.5 | -1.7 | 0.1 | -0.2 | -0.5 | -0.6 | -1.0 | -0.9 | -1.3 | -1.6 | -13 | -0.6 | 12 | -13 | -8.8 | -21 | -1.6 | 15 | 13 | -4.7 | 3.2 | 0.3 | -2.4 | -3.0 | -4.9 | -8.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.1 | 23 | 0.0 | – | – | – | – | |
| – | -1.3 | – | – | – | – | – | – | – | – | – | – | – | – | 4.8 | 18 | 52 | 80 | -2.9 | 0.1 | -2.3 | 22 | -0.3 | 0.0 | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 19 | -21 | – | -1.1 | -1.1 | -1.1 | -1.1 | 22 | -2.3 | -13 | -3.5 | -1.2 | -1.2 | |
| 1.9 | 4.6 | – | 0.1 | 2.5 | 0.9 | 0.0 | -0.5 | 1.3 | 6.8 | 13 | 0.0 | 20 | 0.0 | 4.8 | 18 | 70 | 58 | 2.8 | 0.1 | -2.2 | 22 | 21 | 63 | -2.2 | 16 | 11 | 7.3 | 4.3 | |
| 1.9 | 4.6 | -0.8 | -0.9 | -0.1 | -0.1 | 0.1 | 0.1 | 0.1 | 2.4 | 8.4 | -5.5 | 17 | -11 | -6.5 | -1.0 | 7.2 | 54 | -35 | -14 | -8.8 | 14 | -11 | 37 | -35 | -3.2 | -1.1 | 6.7 | -5.0 | |
| -1.8 | -2.7 | -0.9 | -0.8 | -2.0 | -1.5 | 0.1 | 0.6 | -1.1 | -4.4 | -4.3 | -5.5 | -3.0 | 1.3 | -11 | -31 | -51 | 3.6 | -17 | -13 | -23 | -21 | -29 | -31 | -34 | -17 | -9.7 | 3.2 | -1.2 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.